Low dose IL-2 in patients with steroid-dependent dysimmune manifestations associated with myelodysplastic syndromes: a three-case report.
Sign Up to like & getrecommendations! Published in 2020 at "Rheumatology"
DOI: 10.1093/rheumatology/keaa696
Abstract: OBJECTIVES Systemic inflammatory and autoimmune diseases can be associated with myelodysplastic syndromes. Current treatments (steroids, immunosuppressive agents, biologics) are unsatisfactory because of their low response rate, dependence or adverse events. We aimed at evaluating the… read more here.
Keywords: myelodysplastic syndromes; low dose; patients steroid; steroid dependent ... See more keywords
Efficacy and safety of minodronic acid hydrate in patients with steroidâinduced osteoporosis
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.12844
Abstract: Minodronic acid hydrate, an oral bisphosphonate, has a greater inhibitory effect on bone resorption than do other approved drugs; however, this has been studied only in patients with primary osteoporosis. Here, we administered minodronic acid… read more here.
Keywords: patients steroid; minodronic acid; hydrate patients; acid hydrate ... See more keywords
Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of haematology"
DOI: 10.1111/ejh.13987
Abstract: BACKGROUND Evidence regarding health-related quality of life (HRQoL) in patients with steroid-refractory acute graft-versus-host disease (SR-aGvHD) is lacking. Evaluating HRQoL was a secondary objective of the HOVON 113 MSC trial. Here we describe the outcomes… read more here.
Keywords: steroid refractory; disease; quality life; patients steroid ... See more keywords
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab
Sign Up to like & getrecommendations! Published in 2017 at "Gut"
DOI: 10.1136/gutjnl-2016-313060
Abstract: Objective Ciclosporin and infliximab have demonstrated short-term similar efficacy as second-line therapies in patients with acute severe UC (ASUC) refractory to intravenous steroids. The aim of this study was to assess long-term outcome of patients… read more here.
Keywords: ciclosporin infliximab; patients steroid; long term; infliximab ... See more keywords
Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial.
Sign Up to like & getrecommendations! Published in 2018 at "Swiss medical weekly"
DOI: 10.4414/smw.2018.14677
Abstract: BACKGROUND Sarcoidosis is a disorder of unknown aetiology. Most patients have steroid-responsive disease, but side effects and steroid resistance may necessitate alternative treatments. Endothelin has in-vitro fibrogenic activity and the endothelin system is activated in… read more here.
Keywords: trial; capacity; patients steroid; steroid resistant ... See more keywords